AA

Ashish Arajanbhai Savaliya

Active Director Designated Partner DIN 11926535
DIN 11926535 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashish Arajanbhai Savaliya

Ashish Arajanbhai Savaliya is a Designated Partner at Niramay Hospital And Icu Llp (since 2026).

DIN 11926535
Primary Designation Designated Partner
First Appointment 04 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Sep 20262026Active

Board colleagues of Ashish Arajanbhai Savaliya

NameDINCompanyDesignation
Bharatkumar Mevabhai Parmar11926534Niramay Hospital And Icu LlpDesignated Partner
Hirenkumar Kanubhai Vora08314063Niramay Hospital And Icu LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Niramay Hospital And Icu Llp
Premium access

Shareholding and investment profile for Ashish Arajanbhai Savaliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Arajanbhai Savaliya

Ashish Arajanbhai Savaliya currently holds 1 directorship: Niramay Hospital And Icu Llp (Designated Partner, since 04 Sep 2026).

Ashish Arajanbhai Savaliya was first appointed on 04 Sep 2026 as Designated Partner at Niramay Hospital And Icu Llp.

The current boards of Ashish Arajanbhai Savaliya's companies include Bharatkumar Mevabhai Parmar (Niramay Hospital And Icu Llp), Hirenkumar Kanubhai Vora (Niramay Hospital And Icu Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available